Non-LPS targets and actions of LPS binding protein (LBP)

Journal of Endotoxin Research

Volumn 11, Issue 4, 2005, Pages 237-242

  Schröder, Nicolas W J ^a   Schumann, Ralf R ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

BPI PLUNC family; LBP; Lipopolysaccharide; LPS binding protein

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; CELL RECEPTOR; GLYCOLIPID; LIPOPEPTIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; LIPOPROTEIN; LIPOTEICHOIC ACID;

BACTERIAL INFECTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IN VIVO STUDY; INHIBITION KINETICS; INNATE IMMUNITY; INTESTINE; LUNG; MYCOBACTERIUM; MYCOPLASMA; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; SPIROCHETE; TISSUE DISTRIBUTION;

ACUTE-PHASE PROTEINS; ANIMALS; ANTIGENS, CD14; BACTERIAL PROTEINS; CARRIER PROTEINS; FORECASTING; HUMANS; LIPOPOLYSACCHARIDES; LIPOPROTEINS; MEMBRANE GLYCOPROTEINS; MODELS, IMMUNOLOGICAL; PROTEIN BINDING;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOPLASMA; NEGIBACTERIA; POSIBACTERIA;

EID: 25444490358     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805105X37420     Document Type: Review

References (79)

1. Beutler B, Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 2003; 3: 169-176.
2. Rietschel ET, Brade H, Holst O et al. Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr Top Microbiol Immunol 1996; 216: 39-81.
3. Rietschel ET, Cavaillon JM. Endotoxin and anti-endotoxin. The contribution of the schools of Koch and Pasteur: life, milestone-experiments and concepts of Richard Pfeiffer (Berlin) and Alexandre Besredka (Paris). J Endotoxin Res 2002; 8: 71-82.
4. Alexander C, Rietschel ET. Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 2001; 7: 167-202.
5. Tobias PS, Soldau K, Ulevitch RJ. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med 1986; 164: 777-793.
6. Ulevitch RJ, Mathison JC, Schumann RR, Tobias PS. A new model of macrophage stimulation by bacterial lipopolysaccharide. J Trauma 1990; 30 (12 Suppl): S189-S192.
7. Schumann RR, Leong SR, Flaggs GW et al. Structure and function of lipopolysaccharide binding protein. Science 1990; 249: 1429-1431.
8. Mathison JC, Tobias PS, Wolfson E, Ulevitch RJ. Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of Gram-negative LPS. J Immunol 1992; 149: 200-206.
9. Lamping N, Hoess A, Yu B et al. Effects of site-directed mutagenesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activation. J Immunol 1996; 157: 4648-4656.
10. Schumann RR, Lamping N, Hoess A. Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities. J Immunol 1997; 159: 5599-5605.
11. Han J, Mathison JC, Ulevitch RJ, Tobias PS. Lipopolysaccharide (LPS) binding protein, truncated at Ile-197, binds LPS but does not transfer LPS to CD14. J Biol Chem 1994; 269: 8172-8175.
12. Hailman E, Lichenstein HS, Wurfel MM et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 1994; 179: 269-277.
13. Tobias PS, Soldau K, Gegner JA, Mintz D, Ulevitch RJ. Lipopolysaccharide binding protein-mediated cemplexation of lipopolysaccharide with soluble CD14. J Biol Chem 1995; 270: 10482-10488.
14. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-1433.
15. Schumann RR, Rietschel ET, Loppnow H. The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin. Med Microbiol Immunol (Berl) 1994; 183: 279-297.
16. Thompson PA, Tobias PS, Viriyakosol S, Kirkland TN, Kitchens RL. Lipopolysaccharide (LPS)-binding protein inhibits responses to cell-bound LPS. J Biol Chem 2003; 278: 28367-28371.
17. Tobias PS, Tapping RI, Gegner JA. Endotoxin interactions with lipopolysaccharide-responsive cells. Clin Infect Dis 1999; 28: 476-481.
18. Gegner JA, Ulevitch RJ, Tobias PS. Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J Biol Chem 1995; 270: 5320-5325.
19. Hamann L, Stamme C, Ulmer AJ, Schumann RR. Inhibition of LPS-induced activation of alveolar macrophages by high concentrations of LPS-binding protein. Biochem Biophys Res Commun 2002; 295: 553-560.
20. Lamping N, Dettmer R, Schröder NWJ et al. LPS-binding protein protects mice from septic shock caused by LPS or Gram-negative bacteria. J Clin Invest 1998; 101: 2065-2071.
21. Zweigner J, Gramm HJ, Singer OC, Wegscheider K, Schumann RR. High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood 2001; 98: 3800-3808.
22. Wurfel MM, Kunitake ST, Lichenstein H, Kane JP, Wright SD. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med 1994; 180: 1025-1035.
23. Vreugdenhil AC, Rousseau CH, Hartung T, Greve JW, van't Veer C, Buurman WA. Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons. J Immunol 2003; 170: 1399-1405.
24. Kitchens RL, Thompson PA. Impact of sepsis-induced changes in plasma on LPS interactions with monocytes and plasma lipoproteins: roles of soluble CD14, LBP, and acute phase lipoproteins. J Endotoxin Res 2003; 9: 113-118.
25. Hamann L, Alexander C, Stamme C, Zahringer U, Schumann RR. Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms. Infect Immun 2005; 73: 193-200.
26. Gutsmann T, Müller M, Carroll SF, MacKenzie RC, Wiese A, Seydel U. Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells. Infect Immun 2001; 69: 6942-6950.
27. Müller M, Brandenburg K, Dedrick R, Schromm AB, Seydel U. Phospholipids inhibit lipopolysaccharide (LPS)-induced cell activation: a role for LPS-binding protein. J Immunol 2005; 174: 1091-1096.
28. Müller M, Scheel O, Lindner B, Gutsmann T, Seydel U. The role of membrane-bound LBP, endotoxin aggregates, and the MaxiK channel in LPS-induced cell activation. J Endotoxin Res 2003; 9: 181-186.
29. Grube BJ, Cochane CG, Ye RD et al. Lipopolysaccharide binding protein expression in primary human hepatocytes and HepG2 hepatoma cells. J Biol Chem 1994; 269: 8477-8482.
30. Schumann RR, Kirschning CJ, Unbehaun A et al. The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins. Mol Cell Biol 1996; 16: 3490-3503.
31. Sablotzki A, Borgermann J, Baulig W et al. Lipopolysaccharide-binding protein (LBP) and markers of acute-phase response in patients with multiple organ dysfunction syndrome (MODS) following open heart surgery. Thorac Cardiovasc Surg 2001; 49: 273-278.
32. Schäfer K, Schumann RR, Stoteknuel S, Schollmeyer P, Dobos GJ. Lipopolysaccharide-binding protein is present in effluents of patients with Gram-negative and Gram-positive CAPD peritonitis. Nephrol Dial Transplant 1998; 13: 969-974.
33. Erwin PJ, Lewis H, Dolan S et al. Lipopolysaccharide binding protein in acute pancreatitis. Crit Care Med 2000; 28: 104-109.
34. Albillos A, de la Hera A, Gonzalez M et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 2003; 37: 208-217.
35. Schumann RR, Zweigner J. A novel acute-phase marker: lipopolysaccharide binding protein (LBP). Clin Chem Lab Med 1999; 37: 271-274.
36. Oude Nijhuis CS, Vellenga E, Daenen SM et al. Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients. Intensive Care Med 2003; 29: 2157-2161.
37. Kaden J, Zwerenz P, Lambrecht HG, Dostatni R. Lipopolysaccharide-binding protein as a new and reliable infection marker after kidney transplantation. Transpl Int 2002; 15: 163-172.
38. Pavcnik-Arnol M, Hojker S, Derganc M. Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein. Intensive Care Med 2004; 30: 1454-1460.
39. Behrendt D, Dembinski J, Heep A, Bartmann P. Lipopolysaccharide binding protein in preterm infants. Arch Dis Child 2004; 89: F551-F554.
40. Henneke P, Osmers I, Bauer K, Lamping N, Versmold HT, Schumann RR. Impaired CD14-dependent and independent response of polymorphonuclear leukocytes in preterm infants. J Perinat Med 2003; 31: 176-183.
41. Hallatschek W, Fiedler G, Kirschning CJ et al. Inhibition of hepatic transcriptional induction of lipopolysaccharide-binding protein by transforming-growth-factor beta 1. Eur J Immunol 2004; 34: 1441-1450.
42. Vreugdenhil AC, Dentener MA, Snoek AM, Greve JW, Buurman WA. Lipopolysaccharide binding protein and serum amyloid A secretion by human intestinal epithelial cells during the acute phase response. J Immunol 1999; 163: 2792-2798.
43. Dentener MA, Vreugdenhil AC, Hoet PH et al. Production of the acute-phase protein lipopolysaccharide-binding protein by respiratory type II epithelial cells: implications for local defense to bacterial endotoxins. Am J Respir Cell Mol Biol 2000; 23: 146-153.
44. Ren L, Jin L, Leung WK. Local expression of lipopolysaccharide-binding protein in human gingival tissues. J Periodontal Res 2004; 39: 242-248.
45. Li XH, Gong JP, Tu B, Shi YJ, Liu CA. In vivo expression of lipopolysaccharide binding protein and its gene induced by endotoxin. Chin J Traumatol 2003; 6: 280-283.
46. Fan X, Stelter F, Menzel R et al. Structures in Bacillus subtilis are recognized by CD14 in a lipopolysaccharide binding protein-dependent reaction. Infect Immun 1999; 67: 2964-2968.
47. Schröder NWJ, Opitz B, Lamping N et al. Involvement of lipopolysaccharide binding protein, CD14, and Toll-like receptors in the initiation of innate immune responses by Treponema glycolipids. J Immunol 2000; 165: 2683-2693.
48. Opitz B, Schröder NWJ, Spreitzer I et al. Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-kappaB translocation. J Biol Chem 2001; 276: 22041-22047.
49. Morath S, Geyer A, Hartung T. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J Exp Med 2001; 193: 393-397.
50. Schröder NWJ, Morath S, Alexander C et al. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem 2003; 278: 15587-15594.
51. Hermann C, Spreitzer I, Schröder NWJ et al. Cytokine induction by purified lipoteichoic acids from various bacterial species - role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release. Eur J Immunol 2002; 32: 541-551.
52. Vignal C, Guerardel Y, Kremer L et al. Lipomannans, but not lipoarabinomannans, purified from Mycobacterium chelonae and Mycobacterium kansasii induce TNF-alpha and IL-8 secretion by a CD14-Toll-like receptor 2-dependent mechanism. J Immunol 2003; 171: 2014-2023.
53. Ma Y, Weis JJ. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect Immun 1993; 61: 3843-3853.
54. Mühlradt PF, Kiess M, Meyer H, Süssmuth R, Jung G. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J Exp Med 1997; 185: 1951-1958.
55. Mühlradt PF, Kiess M, Meyer H, Süssmuth R, Jung G. Structure and specific activity of macrophage-stimulating lipopeptides from Mycoplasma hyorhinis. Infect Immun 1998; 66: 4804-4810.
56. Schröder NWJ, Heine H, Alexander C et al. Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses. J Immunol 2004; 173: 2683-2691.
57. Weber JR, Freyer D, Alexander C et al. Recognition of pneumococcal peptidoglycan: an expanded, pivotal role for LPS binding protein. Immunity 2003; 19: 269-279.
58. Steiner H. Peptidoglycan recognition proteins: on and off switches for innate immunity. Immunol Rev 2004; 198: 83-96.
59. Jack RS, Fan X, Bernheiden M et al. Lipopolysaccharide-binding protein is required to combat a murine Gram-negative bacterial infection. Nature 1997; 389: 742-745.
60. Fan MH, Klein RD, Steinstraesser L et al. An essential role for lipopolysaccharide-binding protein in pulmonary innate immune responses. Shock 2002; 18: 248-254.
61. Yang KK, Dorner BG, Merkel U et al. Neutrophil influx in response to a peritoneal infection with Salmonella is delayed in lipopolysaccharide-binding protein or CD14-deficient mice. J Immunol 2002; 169: 4475-4480.
62. Fierer J, Swancutt MA, Heumann D, Golenbock D. The role of lipopolysaccharide binding protein in resistance to Salmonella infections in mice. J Immunol 2002; 168: 6396-6403.
63. Branger J, Florquin S, Knapp S et al. LPS-binding protein-deficient mice have an impaired defense against Gram-negative but not Gram-positive pneumonia. Int Immunol 2004; 16: 1605-1611.
64. Asai Y, Hashimoto M, Ogawa T. Treponemal glycoconjugate inhibits Toll-like receptor ligand-induced cell activation by blocking LPS-binding protein and CD14 functions. Eur J Immunol 2003; 33: 3196-3204.
65. Hashimoto M, Asai Y, Ogawa T. Treponemal phospholipids inhibit innate immune responses induced by pathogen-associated molecular patterns. J Biol Chem 2003; 278: 44205-44213.
66. Weiss J, Muello K, Victor M, Elsbach P. The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope. J Immunol 1984; 132: 3109-3115.
67. Beamer LJ, Carroll SF, Eisenberg D. The BPI/LBP family of proteins: a structural analysis of conserved regions. Protein Sci 1998; 7: 906-914.
68. Tobias PS, Mathison JC, Ulevitch RJ. A family of lipopolysaccharide binding proteins involved in responses to gram-negative sepsis. J Biol Chem 1988; 263: 13479-13481.
69. Gray PW, Corcorran AE, Eddy Jr RL, Byers MG, Shows TB. The genes for the lipopolysaccharide binding protein (LBP) and the bactericidal permeability increasing protein (BPI) are encoded in the same region of human chromosome 20. Genomics 1993; 15: 188-190.
70. Kirschning CJ, Au-Young J, Lamping N et al. Similar organization of the lipopolysaccharide-binding protein (LBP) and phospholipid transfer protein (PLTP) genes suggests a common gene family of lipid-binding proteins. Genomics 1997; 46: 416-425.
71. Hubacek JA, Buchler C, Aslanidis C, Schmitz G. The genomic organization of the genes for human lipopolysaccharide binding protein (LBP) and bactericidal permeability increasing protein (BPI) is highly conserved. Biochem Biophys Res Commun 1997; 236: 427-430.
72. Yu B, Hailman E, Wright SD. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. J Clin Invest 1997; 99: 315-324.
73. Elsbach P. The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense. J Leukoc Biol 1998; 64: 14-18.
74. Elsbach P, Weiss J. Role of the bactericidal/permeability-increasing protein in host defence. Curr Opin Immunol 1998; 10: 45-49.
75. Gioannini TL, Teghanemt A, Zarember KA, Weiss JP. Regulation of interactions of endotoxin with host cells. J Endotoxin Res 2003; 9: 401-408.
76. Mulero JJ, Boyle BJ, Bradley S et al. Three new human members of the lipid transfer/lipopolysaccharide binding protein family (LT/LBP). Immunogenetics 2002; 54: 293-300.
77. Bingle CD, Craven CJ. Meet the relatives: a family of BPI- and LBP-related proteins. Trends Immunol 2004; 25: 53-55.
78. Wheeler TT, Haigh BJ, McCracken JY, Wilkins RJ, Morris CA, Grigor MR. The BSP30 salivary proteins from cattle, LUNX/PLUNC and von Ebner's minor salivary gland protein are members of the PSP/LBP superfamily of proteins. Biochim Biophys Acta 2002; 1579: 92-100.
79. Gioannini TL, Teghanemt A, Zhang D et al. Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations. Proc Natl Acad Sci USA 2004; 101: 4186-4191.